-
Selumetinib granted orphan status for NF1 treatment
-
Immunotherapy trial for prostate cancer patients
-
Activated platelets can promote tumor cell invasion into healthy tissue
-
Focusing on function to mine cancer genome data
-
Phase I clinical trial will test multi-targeted immunotherapy in common childhood cancer
-
Application process is open! Lasker #clinicalresearch Scholar positions available. Learn more about the program and… https://t.co/Um85GgmFsJ
-
Much thanks to all organizers, speakers, poster presenters and attendees for a very successful symposium… https://t.co/AHYwaGJwyG
-
RT @BernardAFox: Excited to represent Robert W Franz Cancer Center @ChilesResearch @ProvHealth @DefiniensLife 2 discuss strategies 2… https://t.co/Cv9p2rRRnx
-
RT @NCIprevention: Lung #cancer is the leading cause of cancer death in both men and women. Key points to prevent this disease. #lcsm… https://t.co/efDhN0uedv
-
Finishing up Day 2 of #NCISingleCell2018 with a 12:30pmET talk from @NIAIDNews Andrea Radtke on 2D and 3D #imaging https://t.co/Mo2NMKmJGY
-
We welcome Joe Beechem @nanostringtech to speak at 12:00pmET on mRNA and optical barcodes #NCISingleCell2018 https://t.co/zvtMR05wI4
-
#NCISingleCell2018 Eleen Shum @bdgenomics will discuss the rhapsody system during her 11:30amET talk https://t.co/afrnFMki0r
